# Immune Cell Subgroups in Covid 19 Patients

> **NCT04531319** · — · COMPLETED · sponsor: **Istanbul Training and Research Hospital** · enrollment: 50 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Flow cytometric analysis

## Key facts

- **NCT ID:** NCT04531319
- **Lead sponsor:** Istanbul Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-15
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04531319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04531319, "Immune Cell Subgroups in Covid 19 Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04531319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*